peripheral neuropathy is a disorder of the peripheral nervous system characterized by damage, degeneration, or dysfunction of one or more peripheral nerves, manifesting as impaired sensation, muscle weakness, pain, or autonomic dysfunction predominantly affecting the distal extremities in a “stocking-glove” distribution. It is distinguished from central neuropathy and radiculopathy by its involvement of nerves distal to the nerve root and outside the central nervous system, and from mononeuritis multiplex by its typically symmetric, length-dependent pattern (though asymmetric variants exist). The underlying pathophysiology involves axonal degeneration (dying-back phenomenon from distal to proximal), segmental demyelination, or both, driven by metabolic, toxic, immune-mediated, infectious, or hereditary mechanisms that disrupt axonal transport, myelin integrity, or Schwann cell function. It may be physiological in limited contexts (e.g., age-related mild sensory changes) but is overwhelmingly pathological (e.g., diabetic distal symmetric polyneuropathy E11.40, chemotherapy-induced neuropathy G62.0, Guillain-Barré syndrome G61.0). Clinically relevant subtypes commonly encountered in coding include diabetic peripheral neuropathy (E11.40-E11.49, E10.40-E10.49), hereditary motor and sensory neuropathy/Charcot-Marie-Tooth disease (G60.0), inflammatory demyelinating polyneuropathy (G61.8), toxic/drug-induced neuropathy (G62.0-G62.2), critical illness polyneuropathy (G62.81), and idiopathic/unspecified polyneuropathy (G62.9). It is commonly confused with radiculopathy, which involves compression or irritation at the nerve root level (producing dermatomal rather than stocking-glove patterns), and with mononeuropathy, which affects a single named nerve (e.g., carpal tunnel syndrome G56.00) rather than multiple nerves in a symmetric distribution.
Adjective-forming suffix — “pertaining to” or “characteristic of”
The compound entered English medical usage in the 1950s-1960s as peripheral neuropathy (noun phrase), formed within modern medical Latin from French neuropathie périphérique, from Greek roots. “Peripheral” itself derives from Greek periphereia (περιφέρεια, “circumference”), from peri- (“around”) + pherein (“to carry, to bear”). The root neur- (“nerve, sinew”) connects peripheral neuropathy to the entire -neur- family: neurology (neur- + -logy → study of nerves), neuralgia (neur- + -algia → nerve pain), neuritis (neur- + -itis → nerve inflammation), neuropathology (neur- + -pathology → study of nerve disease), and neurotrophic (neur- + -trophic → nerve-nourishing). The prefix peri- is highly productive in medical terminology — appearing in pericardium, peritoneum, periosteum, perinatal, and perioperative.
🔀 ALIASES / ALTERNATE TERMS
Peripheral Polyneuropathy adjective/noun form — emphasizes involvement of multiple peripheral nerves; common clinical collocations include “diabetic peripheral polyneuropathy,” “toxic peripheral polyneuropathy,” “chronic peripheral polyneuropathy”)
Sensorimotor Neuropathy lay and clinical term; emphasizes combined sensory and motor fiber involvement; especially used in diabetic, hereditary, and chemotherapy settings)
Distal Symmetric Polyneuropathy (DSPN) partial/lesser form — the most common subtype, defined by length-dependent, symmetric involvement of distal sensory fibers first; the prototype of diabetic neuropathy)
Stocking-Glove Neuropathy clinical descriptor synonym — describes the characteristic distribution pattern of sensory loss ascending from feet and hands; coded under G62.9 when idiopathic)
Axonal Neuropathy etiologic subtype 1 — defined by primary axonal degeneration with “dying-back” pattern; NCS shows reduced amplitudes with preserved conduction velocities)
Demyelinating Neuropathy etiologic subtype 2 — defined by primary myelin damage with relative axonal preservation; NCS shows slowed conduction velocities, prolonged latencies, conduction block)
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) anatomic/etiologic subtype — chronic progressive or relapsing immune-mediated demyelination over >8 weeks; G61.81)
Mononeuritis Multiplex anatomic subtype — asymmetric, asynchronous involvement of multiple individual named nerves, often vasculitic; G63 when in classified diseases, otherwise G61.8)
Small Fiber Neuropathy anatomic subtype — selective damage to unmyelinated C-fibers and thinly myelinated A-delta fibers; presents with burning pain and autonomic symptoms with normal routine NCS; G62.89)
Autonomic Neuropathy anatomic subtype — damage to autonomic fibers causing orthostatic hypotension, gastroparesis, erectile dysfunction; G99.0 when in classified diseases, G90.8 otherwise)
Cranial Neuropathy anatomic subtype — involvement of cranial nerves rather than limb nerves; e.g., Bell’s palsy G51.0, trigeminal neuralgia G50.0)
🔗 RELATED TERMS
Central Neuropathy — the opposite/topographic counterpart of peripheral neuropathy; involves damage within the CNS (brain or spinal cord), producing upper motor neuron signs (hyperreflexia, spasticity, Babinski sign) rather than lower motor neuron signs (areflexia, flaccidity, fasciculations)
Neuropathic Pain — shares the -neur- and -pathy roots; disordered pain signaling arising from lesion or disease of the somatosensory nervous system, often a direct consequence of peripheral neuropathy
Radiculopathy — define and distinguish from peripheral neuropathy; nerve root compression or irritation at the spinal level (e.g., M54.10, M54.12-M54.18), producing dermatomal sensory loss and myotomal weakness rather than stocking-glove distribution
Mononeuropathy — single-nerve involvement (e.g., G56.00 carpal tunnel syndrome, G57.00 sciatic neuropathy) versus multi-nerve symmetric involvement in polyneuropathy
Myopathy — primary muscle disease (e.g., G72.9) producing proximal weakness without sensory loss, distinguished from neuropathy by EMG findings and clinical pattern
Neurapraxia — mildest form of peripheral nerve injury (Seddon classification), conduction block without structural disruption; usually reversible
Axonotmesis — more severe peripheral nerve injury with axonal disruption but intact connective tissue sheaths; Wallerian degeneration occurs with potential for regeneration
Neurotmesis — most severe peripheral nerve injury with complete transection; requires surgical repair
Diabetic Neuropathy — disease entity defined by this term; includes distal symmetric polyneuropathy (E11.40-E11.49), autonomic neuropathy (E11.43), and mononeuropathy (E11.44) variants
Charcot-Marie-Tooth Disease — hereditary motor and sensory neuropathy; genetic disease defined by this term (G60.0, subtypes G60.0-G60.8)
Guillain-Barré Syndrome — acute inflammatory demyelinating polyneuropathy defined by this term (G61.0)
Alcoholic Neuropathy — toxic-nutritional neuropathy defined by thiamine deficiency and direct ethanol toxicity (G62.1)
Chemotherapy-Induced Peripheral Neuropathy (CIPN) — iatrogenic toxic neuropathy, especially with platinum agents, taxanes, and vinca alkaloids (G62.0)
Nerve Conduction Study (NCS) — primary diagnostic procedure for evaluating peripheral neuropathy, measuring conduction velocities, amplitudes, and latencies to distinguish axonal vs. demyelinating patterns
Electromyography (EMG) — companion diagnostic procedure; needle examination of muscle electrical activity to confirm denervation and localize the neuropathic process
CODING CORNER
🏥 ICD-10-CM CODES
Polyneuropathies and Other Disorders of the Peripheral Nervous System (G60-G64)
Self-care/home management training, each 15 minutes
64450
Injection, anesthetic agent; other peripheral nerve or branch
64483
Injection, anesthetic agent and/or steroid; transforaminal epidural, lumbar or sacral, single level
64484
Injection, anesthetic agent and/or steroid; transforaminal epidural, lumbar or sacral, each additional level
64555
Percutaneous implantation of neurostimulator electrode array; peripheral nerve
64568
Incision for implantation of cranial nerve neurostimulator electrode array and pulse generator
64581
Incision for implantation of peripheral or cranial nerve neurostimulator electrode array (open)
⚠️ Coding Note: When coding peripheral neuropathy, site-specificity and etiology drive code selection — diabetic neuropathy requires the diabetes code first (E11.42 for type 2 with polyneuropathy) followed by any manifestation codes if additional specificity is needed, and the combination codes already embed the neuropathy diagnosis, so do not report an additional G62.9 or G63 unless the neuropathy type is distinct from the combination code. Sequencing logic: code the underlying etiology (diabetes, toxin, hereditary disorder) first, then the neuropathy manifestation — except when using combination codes like E11.42, which serve as both etiology and manifestation. Undercoding alert: clinicians often document “peripheral neuropathy” without specifying axonal vs. demyelinating, or fail to document “diabetic polyneuropathy” when the diabetes link is established — documentation trigger phrases like “burning feet,” “stocking-glove numbness,” “positive Romberg,” “decreased ankle reflexes,” or “diabetic foot with neuropathy” should prompt a query for more specific coding. Payer considerations: many Medicare Advantage plans require NCS/EMG prior authorization using codes 95907-95913 and 95860-95864; use modifier -59 or -X{EPSU} modifiers when performing EMG and NCS on the same date if distinct studies are performed, and modifier -25 when an E/M service is provided on the same day as diagnostic testing. Type/subtype specificity: for CIDP (G61.81) versus AIDP/GBS (G61.0), documentation must specify acute (<4 weeks progression) vs. chronic (>8 weeks) course, and for hereditary neuropathies, genetic testing confirmation and specific subtype (CMT1A, CMT2, etc.) is often required for treatment authorization (e.g., IVIG for CIDP).
Crystal's Coder Hub